Advertisement

Baicalin

  • Li Li
  • Li Zhang
  • Guan-Hua Du
Chapter

Abstract

Baicalin, a flavone glycoside, is the glucuronide of baicalein. As one of the effective components from radix scutellariae, baicalin has a variety of pharmacological activities such as antiviral, antivirus, removal of oxygen free radicals, antioxidant, antipyretic, analgesic, anti-inflammatory, antitumor, cardiovascular protecting, cerebrovascular and neuron protecting, liver protecting, and prevention or treatment of diabetes and its complications. It can be used alone or in combination with other drugs for the treatment of the disease such as acute and chronic hepatitis and persistent hepatitis. However, due to the low bioavailability of baicalin, a large number of studies have shown that baicalein is the ingredient with more prominent activities compared with baicalin. Therefore, it is a potent valuable drug and deserves further research and development.

Keywords

Baicalin Baicalein Radix scutellariae Hepatitis 

References

  1. 1.
    Zeng GF, Zhang ZR. Studies on the yellow alkaloids in traditional Chinese medicine V, studies on chemical constituents of Scutellaria baicalensis (first report) new extraction method of Carbosil and its new methylation. Acta Pharm Sin. 1957;5(1):47–57. (In Chinese)Google Scholar
  2. 2.
    Baicalin. The free encyclopedia. In: Wikipedia, from https://en.wikipedia.org/wiki/Baicalin. Retrieved 20:01, 7 June 2016.
  3. 3.
    Wang WY, Dai JY, Sun SJ, et al. Advances in pharmacokinetics of baicalein. Modernization Tradit Chin Med Mater Med World Sci Technol. 2011;13(6):1018–21. (In Chinese)Google Scholar
  4. 4.
    Guo M, Wu ZL, Gao XY. Epid toxicity of baicalin-metal complexes on human hepatocellular carcinoma SMMC-7721 cells and its association with DNA interactions in hepatocellular carcinoma cells. Chin J Pharmacol Toxicol. 2014;28(4):536–49. (In Chinese)Google Scholar
  5. 5.
    Xin WY, Song JK, He GR, et al. Advances in pharmacological effects and mechanism of baicalein and baicalin. Chin J New Drugs. 2013;22(6):647–59. (In Chinese)Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2018

Authors and Affiliations

  1. 1.Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Centre for Pharmaceutical ScreeningInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

Personalised recommendations